relatlimab
Sign in to saveAlso known as BMS-986016
Relatlimab is a monoclonal antibody designed for the treatment of melanoma. It is used in combination with nivolumab to treat melanoma.
~2 min read
Article
3 sectionsContents
- History
- Names
- References
Relatlimab is a monoclonal antibody designed for the treatment of melanoma. It is used in combination with nivolumab to treat melanoma.
Relatlimab is a Lymphocyte activation gene-3 (LAG-3) inhibitor. It is under development by Bristol-Myers Squibb. It is made using Chinese hamster ovary cells.
Connections
monoclonal antibody
Entity
Bristol-Myers Squibb
Entity
lumiliximab
Entity
human
Entity
protein
Entity
International Standard Book Number
Entity
immunity
Entity
Wayback Machine
Entity
digital object identifier
Entity
chemical formula
Entity
molar mass
Entity
melanoma
Entity
Q180686
Entity
antigen
Entity
CAS Registry Number
Entity
Q229883
Entity
Anatomical Therapeutic Chemical Classification System
Entity
intravenous infusion and defusion
Entity
clinical trial
Entity
World Health Organization Model List of Essential Medicines
Entity